Cardio-Renal Clinical Challenges
-15%
portes grátis
Cardio-Renal Clinical Challenges
Spaak, Jonas; Goldsmith, David; Covic, Adrian
Springer International Publishing AG
09/2016
234
Mole
Inglês
9783319348704
15 a 20 dias
6126
Descrição não disponível.
Epicardial coronary heart disease in chronic kidney disease: diagnosis and management.- Small vessel disease in CKD, Diabetes, obesity and Hypertension.- Sudden Cardiac Death and Arrhythmia in Chronic Kidney Disease.- Anticoagulation in Chronic Kidney Disease.- MRA inhibition in CKD: more than salt and water.- Vascular effects of inflammation and oxidative stress in CKD.- Uric acid, allopurinol: the cardio-renal silver bullet?.- FGF23 and phosphate: two cardiovascular toxins with distinct toxicity profiles?.- Renal congestion in heart failure.- Effect of Vitamin D on Endothelial Function and Blood Pressure.- Vitamin D and its effects on the heart.- Volume overload in chronic kidney disease: Pathophysiology, Assessment techniques, Consequences and Treatment.- Reversing Arterial Stiffening And Calcification - A Pipe Dream?.- Pulmonary Hypertension in Chronic Kidney Disease: a new problem child.- How To Use Inhibitors Of The Renin-Angiotensin-Aldosterone System In Patients With Chronic Kidney Disease And Heart Failure.- Erectile and sex hormone dysfunction and cardiovascular consequences in chronic kidney disease.- Renal Sympathetic Denervation in the Management of Treatment-Resistant Hypertension.- Future Therapeutic Prospects for Treatment of Cardiorenal Syndromes.- Novel combination therapy to target heart and kidney.- Challenging complex diseases.- Is "Me, Me, Me" the new "We, We, We"? : Can we afford (not) to take the plunge into the personalised, stratified medicine era?.- Psychological distress in physical long-term conditions.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Anticoagulation;Arrhythmia;Arterial Stiffening;CKD;CVD;Calcification;Cardio-renal;Cardiovascular Disease;Chronic Kidney Disease;Coronary Artery Disease;Diabetes;Epicardial coronary heart disease;FGF23;MRA inhibition;Pulmonary Hypertension;Renal denervation;Sudden Cardiac Death;Uric acid;Vitamin D;Volume overload;heart failure;oxidative stress
Epicardial coronary heart disease in chronic kidney disease: diagnosis and management.- Small vessel disease in CKD, Diabetes, obesity and Hypertension.- Sudden Cardiac Death and Arrhythmia in Chronic Kidney Disease.- Anticoagulation in Chronic Kidney Disease.- MRA inhibition in CKD: more than salt and water.- Vascular effects of inflammation and oxidative stress in CKD.- Uric acid, allopurinol: the cardio-renal silver bullet?.- FGF23 and phosphate: two cardiovascular toxins with distinct toxicity profiles?.- Renal congestion in heart failure.- Effect of Vitamin D on Endothelial Function and Blood Pressure.- Vitamin D and its effects on the heart.- Volume overload in chronic kidney disease: Pathophysiology, Assessment techniques, Consequences and Treatment.- Reversing Arterial Stiffening And Calcification - A Pipe Dream?.- Pulmonary Hypertension in Chronic Kidney Disease: a new problem child.- How To Use Inhibitors Of The Renin-Angiotensin-Aldosterone System In Patients With Chronic Kidney Disease And Heart Failure.- Erectile and sex hormone dysfunction and cardiovascular consequences in chronic kidney disease.- Renal Sympathetic Denervation in the Management of Treatment-Resistant Hypertension.- Future Therapeutic Prospects for Treatment of Cardiorenal Syndromes.- Novel combination therapy to target heart and kidney.- Challenging complex diseases.- Is "Me, Me, Me" the new "We, We, We"? : Can we afford (not) to take the plunge into the personalised, stratified medicine era?.- Psychological distress in physical long-term conditions.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Anticoagulation;Arrhythmia;Arterial Stiffening;CKD;CVD;Calcification;Cardio-renal;Cardiovascular Disease;Chronic Kidney Disease;Coronary Artery Disease;Diabetes;Epicardial coronary heart disease;FGF23;MRA inhibition;Pulmonary Hypertension;Renal denervation;Sudden Cardiac Death;Uric acid;Vitamin D;Volume overload;heart failure;oxidative stress
